Clindamycin is an antimicrobial from the lincomycin group of antibiotics. Clindamycin is a semi-synthetic product in which the hydroxyl group in the seventh position of the lincomycin molecule is replaced with a chloride ion. Lincomycin is produced by Streptomyces. The most important feature of Clindamycin is that it has a powerful antibacterial effect on all types of anaerobic bacteria, significant activity against aerobic Gram-positive bacteria, and inhibitory effect on some aerobic Gram-negative cocci, Mycoplasma hominis and Chlamydia trachomatis. Clinically, it can be used for gram-positive bacteria causing tonsillitis, myelitis and pyelonephritis and anaerobic bacteria causing skin and soft tissue infections, sepsis, anaerobic pneumonia and endometritis infections and other diseases. Clindamycin can cause pseudomembranous enteritis, hepatic and renal impairment, leukopenia and other adverse reactions, allergic to clindamycin is prohibited, the use of drugs should be used under the guidance of a professional doctor on medical advice, do not blindly use their own medication.